Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Obesity slowly undoing progress made in decreasing CVD
-
- Consolidation and hybridization in the health care enterprise: How are cardiologists affected? L. Samuel Wann, MD, MACC, FESC
- AF-stroke relationship strongest in black patients
- Anticoagulation use in older patients with AF, CKD confers mixed outcomes
- Cardiac biomarkers, low BMI may predict poor outcomes in muscular dystrophy
- Cardiac MRI appropriate for assessing mitral regurgitation
- Cocaine use confers epicardial, microvascular disease
- Congenital heart disease increases risk for dementia
- CV risk factors visible in retinal images
-
- Greater waist, hip measurements increase risk for MI in women
- More than a third of physicians meet burnout criteria
- Neighborhood deprivation increases risk for HF
- Role of biomarkers in HFpEF uncertain
- Treatment delays confer excess deaths in STEMI, cardiogenic shock
- Vegetarian, Mediterranean diets equally effective for CVD prevention
- Low systolic BP confers harm in patients with HFpEF
- CANTOS: Canakinumab reduces CV events in CKD, diabetes
-
- Febuxostat noninferior to allopurinol in patients with gout, major CV conditions
- Genetic test for clopidogrel response after PCI helps influence antiplatelet decisions
- Hypertension intervention in barbershops cuts BP levels
- MOMENTUM 3: Newer LVAD improves 2-year outcomes in advanced HF
- ODYSSEY Outcomes: Alirocumab lowers CV events in ACS population
- Personalized approach to antiplatelet drug selection may improve clinical outcomes
- POISE: Higher death, stroke risk persists 1 year after noncardiac surgery in patients treated with metoprolol
- SMART-DATE: Shorter DAPT duration noninferior to longer duration, but increases MI risk
-
- Statin discontinuation common in high-risk patients
- Therapies for prevention of cardiotoxicity in breast cancer confer mixed results
- VEST: Wearable cardioverter defibrillator cuts total mortality, but not sudden death post-MI
- VIDEO: Deepak L. Bhatt, MD, MPH, highlights top takeaways from ACC
- VIDEO: Highlights in the advancing field of cardio-oncology
- VIDEO: PCSK9 inhibitor access remains an issue, but assistance available
- VIDEO: Plant-based diets decrease CV risk
- VIP-U: Psoriasis treatment reduces vascular inflammation
-
- Trial Scorecard: CASA
- Trial Scorecard: CECCY
- Trial Scorecard: INDIE-HFpEF
- Trial Scorecard: mSToPS
- Trial Scorecard: ODYSSEY Outcomes
- Trial Scorecard: SMART-DATE
- Trial Scorecard: VEST
- Trial Scorecard: VIP-U
-